Cite this paper
I. Şimşek, M. Ergüven and O. Dağcı, "Evaluation of Tuberculin Skin Test Response and Interfering Factors in Patients with Juvenile Idiopathic Arthritis," Open Journal of Rheumatology and Autoimmune Diseases
, Vol. 3 No. 4, 2013, pp. 181-184. doi: 10.4236/ojra.2013.34028
 T. J. Cassidy and R. E. Patty, “Juvenile Rheumatoid Arthritis. Textbook of Pediatric Rheumatology,” 3rd Edition, W. B. Saunders, 1995, pp. 133-223.
 R. N. Lipnick, G. C. Tsokov and D. B. Maglavy, “Immune Abnormalities in the Pathogenesis of Juvenile Rheumatoid Arthritis,” Rheumatic Disease Clinics of North America, Vol. 17, 1991, pp. 703-859.
 D. Ponce de Leon, E. Acevedo-Vasquez, A. Sanchez-Torres, et al., “Attenuated Response to Purified Protein Derivative in Patients with Rheumatoid Arthritis: Study in a Population with a High Prevalence of Tuberculosis,” Annals of the Rheumatic Diseases, Vol. 64, 2005, pp. 1360-1361.
 Turkish Ministry of Health Division of Tuberculosis, “Incidence of Tuberculosis and Number of Cases over Years,” 2000.
 American Academy of Pediatrics, “Report of the Committee on Infectious Disease. Red Book,” 24th Edition, 1997, p. 544.
 F. Wolfe, K. Michaud, J. Anderson and K. Urbansky, “Tuberculosis Infection in Patients with Rheumatoid Arthritis and the Effect of Infliximab Therapy,” Arthritis & Rheumatism, Vol. 2, 2004, pp. 372-379.
 H. Güvenc, A. Koc and O. Ozkarakas, “PPD Skin Testing in Schoolchildren with and without BCG Vaccination,” Turkish Journal of Medical Research, Vol. 11, No. 3, 1993, pp. 116-119.
 A. Koc and T. Karagoz, “Tüberkülozda Epidemiyolojik Olcütler ve Hasta Grubu Analizi,” Solunum Hastaliklarn Dergisi, Vol. 8, No. 4, 1997, pp. 621-634.
 R. L. Sepulveda, X. Ferrer and R. U. Sorensen, “The Influence of Calmette Guerin Bacillus Immunization on the Booster Effect to Tuberculin Testing in Healthy Young Adults,” The American Review of Respiratory Disease, Vol. 142, 1990, pp. 24-28.
 G. W. Comstock, L. B. Edwards and X. T. Nabang, “Tuberculin Sensitivity Eight to Fifteen Years after BCG Vaccination,” The American Review of Respiratory Disease, Vol. 103, 1971, pp. 572-575.
 E. S. Ucan, C. Sevinc and O. Abadoglu, “Tüberkülin Testi Sonuclarinin Yorumlanmasi ülkemiz Standartlari ve yeni Gereksinimler,” Toraks Dergisi, Vol. 1, 2000, pp. 25-29.
 E. Bozkanat, F. Ciftci, M. Apaydin, Z. Kartaloglu, E. Tozkoparan, O. Deniz and O. Sezer, “Tuberculin Skin Test Screening in a Military School in Istanbul City Center.”
 A. Sakar, T. Goktalay, L. Dagyildizi and A. C. Yildirim, “Manisa Ilinde Tüberküloz Taramasi,” Toraks Dergisi, 2001.
 J. Waxman, M. D. Lockshin, J. J. Schnapp and I. N. Doneson, “Cellular Immunity in Rheumatic Diseases I. Rheumatoid Arthritis,” Arthritis & Rheumatism, Vol. 4, 1974, pp. 499-506.
 H. M. Hoyeraal, “Impaired Delayed Hypersensitivity in Jüvenile Rheumatoid Arthritis,” Annals of the Rheumatic Diseases, Vol. 32, 1973, p. 331.
 J. R. Hayes, D. J. Ward and J. F. Jennings, “Studies on Cell-Mediated Hypersensitivity Responses in Rheumatoid Arthritis,” Proceedings of the Third Symposium, 1970.
 M. G. Helliwell, G. S. Panayi and A. Unger, “Delayed Cutaneous Hypersensitivity in Rheumatoid Arthritis: The Influence of Nutrition and Drug Therapy,” Clinical Rheumatology, Vol. 1, 1984, pp. 39-45.
 E. Kiray, O. Kasapcopur, V. Bas, et al., “Purified Protein Derivative Response in Juvenile Idiopathic Arthritis,” Journal of Rheumatology, Vol. 36, 2009, pp. 2029-2032.
 I. Sezer, H. Kocabas, M. A. Melikoglu and M. Arman, “Positiveness of Purified Protein Derivatives in Rheumatoid Arthritis Patients Who Are Not Receiving Immuno-suppressive Therapy,” Clinical Rheumatology, Vol. 28, 2009, pp. 53-55.